<DOC>
	<DOCNO>NCT01295736</DOCNO>
	<brief_summary>Digital ulcer ( DUs ) expression microangiopathy patient scleroderma ( SSc ) . DUs lead pain impaired hand use . DUs remain severe complication many patient effective therapy remain elusive . In present study , investigator propose evaluate efficacy Sildenafil DUs heal randomize double blind control study SSc patient .</brief_summary>
	<brief_title>Sildenafil Effect Digital Ulcer Healing sClerodErma SEDUCE STUDY</brief_title>
	<detailed_description>This multicenter , prospective , longitudinal , randomize , comparative , double-blind , 2-parallel-arm , placebo-controlled study aim evaluate efficacy sildenafil 20 mg TID study time heal DUs SSc patient ischaemic DUs . Approximately 120 patient age 18 year allocate receive either placebo sildenafil 20mg TID 90 day . All potential subject present ischaemic digital ulcer complicate scleroderma . An eligible digital ulcer must beyond proximal interphalangeal joint , finger surface ( included periungual ulcer ) , ischemic origin accord physician , subcutaneous calcification bone relief .</detailed_description>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<mesh_term>Scleroderma , Localized</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Patient systemic sclerosis ( ScS ) accord classification criterion American College Rheumatology `` LeRoy '' `` Medsger '' . ScS patient least one ongoing ischaemic hand digital ulcer baseline ( see eligibility condition digital ulcer ) . Patient must provide write informed consent prior enrolment . Patient agree come follow visit inside protocol specify range . Relative DU : DU must beyond proximal interphalangeal joint , finger surface , ischemic origin accord physician , subcutaneous calcification bone relief . PAH require PDE5 inhibitor prostacyclin history stroke , myocardial infarction life threaten arrhythmia within last 6 month severe cardiac failure ( NYHA IV ) unstable angina within last 6 month . hereditary degenerative retinal disorder nonarteritic anterior ischemic optic neuropathy untreated proliferative diabetic retinopathy uncontrolled diabetes mellitus Patient known severe lung obstructive disease ( FEV1 &lt; 70 % last available pulmonary function test ) . severe hepatic impairment Patient know impairment renal function ( serum creatinine &gt; 2.5 ULN ) . Patient severe malabsorption severe organ failure ( e.g. , lung , kidney ) lifethreatening condition . Patient surgical sympathectomy perform previous 12 month . Patient history upper extremity deep vein thrombosis lymphedema within previous 3 month . Patient participate clinical trial participate clinical trial within previous 3 month . Patient receive treatment sildenafil digital ulcer pulmonary arterial hypertension within 3 month prior inclusion . Patient receive treatment parenteral prostanoids ( prostaglandin E , epoprostenol , treprostinil sodium prostacyclin analog ) within 3 month prior inclusion . Patient receive treatment inhaled oral prostanoids one month prior inclusion . Patient previous intolerance allergy PDE5 inhibitor history multiple clinically significant allergy . Pregnant lactate female . Patient uncontrolled tachyarrhythmias bradyarrhythmias , placement pacemaker implantable defibrillator within 60 day prior randomization . Patient hemodynamic instability systolic arterial pressure le 90 mmHg and/or symptomatic orthostatic hypotension . Patient receive form prostacyclin nitrate nitric oxide donor form include Nicorandil . Patient receive potent inhibitor CYP3A4 ketoconazole , itraconazole , ritonavir . Patient condition prevents compliance protocol adhere therapy . Patient donate blood previous month intend donate blood blood product study one month follow completion study . Patient guardianship ( include curator ) deprive liberty . Patient present anatomic malformation penis ( angulation , sclerosis erectile tissue `` Lapeyronie 's disease '' ) . Patient present disease predisposes priapism ( sicklecell disease , myeloma leukemia ) . Patient present least one digital ulcer meeting exclusion criterion ( see ) . Relative DU : Digital ulcer due condition scleroderma . Non ischaemic digital ulcer . Infected digital ulcer require systemic antibiotherapy . Digital ulcer require urgent surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>scleroderma</keyword>
	<keyword>digital</keyword>
	<keyword>ulcer</keyword>
</DOC>